Patents by Inventor Katherine Upchurch-Ange

Katherine Upchurch-Ange has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE
    Publication number: 20240026007
    Abstract: Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.
    Type: Application
    Filed: June 1, 2021
    Publication date: January 25, 2024
    Inventors: Jon Weidanz, Katherine Upchurch-Ange
  • ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE
    Publication number: 20230303701
    Abstract: Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.
    Type: Application
    Filed: June 1, 2021
    Publication date: September 28, 2023
    Inventors: Jon Weidanz, Katherine Upchurch-Ange
  • ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE
    Publication number: 20220332831
    Abstract: Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.
    Type: Application
    Filed: May 13, 2022
    Publication date: October 20, 2022
    Inventors: Jon Weidanz, Katherine Upchurch-Ange
  • Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use
    Patent number: 11359023
    Abstract: Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: June 14, 2022
    Assignee: Boehringer Ingelheim Pharmaceuticals, Inc.
    Inventors: Jon Weidanz, Katherine Upchurch-Ange
  • ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE
    Publication number: 20220033504
    Abstract: Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.
    Type: Application
    Filed: March 11, 2021
    Publication date: February 3, 2022
    Inventors: Jon Weidanz, Katherine Upchurch-Ange
  • ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE
    Publication number: 20210371532
    Abstract: Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.
    Type: Application
    Filed: March 11, 2021
    Publication date: December 2, 2021
    Inventors: Jon Weidanz, Katherine Upchurch-Ange
  • Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use
    Patent number: 10981997
    Abstract: Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: April 20, 2021
    Assignee: ABEXXA BIOLOGICS, INC.
    Inventors: Jon Weidanz, Katherine Upchurch-Ange
  • Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use
    Patent number: 10981996
    Abstract: Provided herein are antibodies that selectively bind to complex comprising a non-classical HLA-I (e.g. HLA-E) and a neoantigen having variable heavy chain domains (VH), variable light chain domains (VL), and complementarity determining regions (CDRs) as disclosed herein, as well as methods and uses thereof.
    Type: Grant
    Filed: July 10, 2020
    Date of Patent: April 20, 2021
    Assignee: ABEXXA BIOLOGICS, INC.
    Inventors: Jon Weidanz, Katherine Upchurch-Ange